Inoviq Limited develops and commercializes diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases, aiming to enhance patient outcomes.
Ticker code: IIQ
Sector: Healthcare | Industry: Diagnostics & Research | Website: https://www.inoviq.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $47,183,724 | $41,038,990 | 138775658 | 60.15 | $28,382,104 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $20,816,349 | $6,520,923 | $376,189 | -40.2 | -480.3 | -29.5 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Negative | 5.0 | $64,394 | $50,961 | 0.58 | 5.4 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $0.340 | -1.4 | -1.4 | -20.0 | -8.1 | -6.8 | -26.9 |
IIQ Price Chart with Volume and 3EMA
IIQ Short Positions
Click HERE to understand why the above moving averages have been chosen.